$ROG

ROGERS CORP (ROG): Results of Operations and Financial Condition

ROGERS CORP (ROG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026resultsannouncement.htm EX-99.1 Document Rogers Corporation Reports Second Quarter 2026 Results • Net sales of $216.8 million increased 6.9% year-over-year (YoY) • Gross margin of 32.5% increased 90 basis points YoY • Net income of $13.6 million, versus a $73.6 mi

Original reporting
Published Jul 28, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 28, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ROG
Bullish
high confidence
Mentioned
$ROG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ROGBullishHigh
01

Why it matters

The filing’s combination of Q2 performance and quantified Q3 guidance (net sales, gross margin, adjusted EPS, adjusted EBITDA, and capex) is actionable for traders updating earnings models and near-term expectations.

02

Market read

Q2 beat/improvement on adjusted EPS and EBITDA margin expansion, plus a specific Q3 guidance range, can drive immediate estimate revisions and sentiment.

03

What to watch

The Q2 year-over-year comparison is influenced by large prior-year impairment and restructuring charges; traders should focus on adjusted metrics and margin trajectory rather than GAAP alone.

Relevance 7/10Novelty 9/10Timing: after-hours/filing today, ahead of the Q2 results conference call at 5:00 pm ET

Background

This is Rogers Corporation’s SEC Form 8-K reporting Q2 2026 results (Item 2.02) and providing Q3 2026 financial outlook.

Company-level read

Ticker impact

$ROGBullishHigh confidence
Context

Rogers reported Q2 2026 net sales of $216.8M (+6.9% YoY) and guided Q3 2026 net sales to $233-$243 with adjusted EPS $1.10-$1.30.

Expected impact

Likely positive bias for the next trading session and into Q3 estimate updates, assuming the market had not fully priced the guidance range.

Evidence & confidence

The filing includes concrete GAAP and non-GAAP results plus explicit Q3 2026 guidance for net sales, gross margin, adjusted EPS, and adjusted EBITDA, which are direct inputs to valuation and near-term expectations.

Market effects

Signals demand improvement in Rogers’ industrial and electronics end markets, potentially supporting sentiment for engineered materials suppliers.

No specific regional macro catalyst beyond general end-market demand and supply chain challenges.

Mentions global operations and currency effects, but no new geopolitical or regulatory shock is disclosed.

Counterpoint

Despite the strong Q2 improvement, the company still cites supply chain challenges, so guidance could be vulnerable to execution or input-cost swings.

Key entities

  • Rogers Corporation

    NYSE-listed engineered materials company reporting Q2 2026 results and issuing Q3 2026 guidance.

  • Ali El-Haj

    President and CEO quoted on revenue growth, adjusted EPS improvement, and outlook for continued year-over-year improvement.

Related articles

$MRNAHighAI 8/10

Why Moderna's Cancer Vaccine Matters To Investors

Moderna (MRNA) and Merck (MRK) reported successful late-stage trial results for a personalized mRNA cancer vaccine targeting melanoma, reducing recurrence risk by 49%. The treatment relies on technologies from Illumina (ILMN), Danaher (DHR), and others. Moderna's stock surged 176.97% on the news, highlighting the shift toward individualized therapies in oncology.

$ROGMedAI 8/10

Why is Rogers stock rallying today? By Investing.com

Rogers stock rose about 3.5% in pre-open after its Q2 2026 results beat expectations, with adjusted EPS of $0.92 on revenue of $216.8 million versus $0.79 and $210.9 million. The company guided Q3 EPS of $1.10–$1.30 and revenue of $233–$243 million. The move follows a prior selloff tied to supply chain headwinds and a plant fire.

$MLKNMed

MLKN Q3 Deep Dive: Margin Strength Offsets Softer Revenue and Lowered Outlook

MillerKnoll (MLKN) reported Q3 revenue of $923.4M, down 3.4% YoY, missing estimates. Q4 guidance of $992M also fell short. Earnings per share beat expectations at $0.53. Management cited delayed projects and softer demand in North America Contract and healthcare, while international orders and retail showed resilience. Cost controls helped margins. The stock trades at $20.57.

$MLKNMedAI 8/10

MillerKnoll (MLKN) Stock Shrugs Off Profit Beat As Tariff Risks Linger

MillerKnoll (MLKN) reported Q1 2027 revenue of $923.4M, down 3.4% YoY, but earnings per share rose 30.1% to $0.38. The stock remained flat post-earnings. Bulls highlight cost discipline and margin improvements, while bears point to tariff risks and soft top-line growth. The company's P/E ratio is 14.1x, and debt coverage remains a focus.

$KBHHighAI 8/10

KB Home (KBH) (Q3 2026) Earnings Call Highlights: Built-to-Order

KB Home (KBH) reported Q3 2026 revenues of $1.3B, down 20% YoY, with net income of $65M. Homes delivered decreased 19% YoY to 2,732. Gross margin was 16.5%, down from 18.2% YoY. The company returned $65M to shareholders and plans up to $50M in Q4 repurchases. Market conditions weakened, with net orders declining and Q4 guidance moderated.